Saracatinib in Treating Patients With Prostate Cancer

Clinical trial NCT01267266 · TERMINATED

Trial details

NCT number: NCT01267266
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone-resistant Prostate Cancer Recurrent Prostate Cancer Stage IV Prostate Cancer

Start date: 2010-12-01
Primary completion: 2012-09-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.